Sequential ¹⁸F‑AV45/¹⁸F‑AV1451 dual‑tracer brain PET imaging in Alzheimer's disease: amyloid‑tau deposition, diagnostic performance, cognitive associations, and modulation by APOE ε4 - Top-Institutions - MDSpire

Sequential ¹⁸F‑AV45/¹⁸F‑AV1451 dual‑tracer brain PET imaging in Alzheimer's disease: amyloid‑tau deposition, diagnostic performance, cognitive associations, and modulation by APOE ε4

  • By

  • Hu, Guomei

  • Feng, Lijuan

  • He, Limeng

  • Liu, Nan

  • Wang, Hao

  • June 8, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology

  • #3

    AVID A16
    AVID A16

    N/A, N/A

    Key Differentiators

    • Neurology

  • #4

    Alzheimer’s Disease Neuroimaging Initiative
    Alzheimer’s Disease Neuroimaging Initiative

    N/A, N/A

    Key Differentiators

    • Neurology

  • #5

    Massachusetts Alzheimer’s Disease Research Center
    Massachusetts Alzheimer’s Disease Research Center

    Boston, MA

    Key Differentiators

    • Neurology

Original Source(s)

Sequential ¹⁸F‑AV45/¹⁸F‑AV1451 dual‑tracer brain PET imaging in Alzheimer's disease: amyloid‑tau deposition, diagnostic performance, cognitive associations, and modulation by APOE ε4

  • by Hu, Guomei , Feng, Lijuan , He, Limeng , Liu, Nan , Wang, Hao

  • June 8, 2026

Related Content

Frontal Release Signs and Future Decline in Research Participants With Intact Cognition

Cognitive Trajectories and Subsequent Accelerometer-Measured Movement Behavior in Older Adults

Pain differences in cognitive impairment appear only during active motor tasks